The specialists of the research center in Washington has developed the drug is a new drug for prevention. In addition to preventing disease, the vaccine slows the growth of cancer education.
The first clinical trials on patients successfully. The vaccine significantly reduces the intensity of tumor growth and increases the duration and quality of life of a person with cancer. It is assumed that the tool can be used in combination with traditional medicines.
According to preliminary data, obtained during the study, the vaccine does not cause complications, no side effects, and its reception is completely safe for the General condition of the human body.